Share Name Share Symbol Market Type Share ISIN Share Description
Unilever Plc LSE:ULVR London Ordinary Share GB00B10RZP78 ORD 3 1/9P
  Price Change % Change Share Price Shares Traded Last Trade
  110.50 3.05% 3,737.00 3,703,850 16:35:17
Bid Price Offer Price High Price Low Price Open Price
3,742.50 3,743.50 3,754.50 3,636.00 3,643.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 44,103.39 7,195.27 195.94 18.6 95,248
Last Trade Time Trade Type Trade Size Trade Price Currency
17:44:43 O 1,724 3,737.00 GBX

Unilever (ULVR) Latest News (1)

More Unilever News
Unilever Investors    Unilever Takeover Rumours
Smart Money!
ULVR is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 

Unilever (ULVR) Discussions and Chat

Unilever Forums and Chat

Date Time Title Posts
24/6/202213:39Unilever - The Dream and Safe Ticket2,519
11/2/202215:16Good Gain Today-
02/2/202220:20::: UNILEVER 2021 :::39
25/1/202216:18Holding Steady-

Add a New Thread

Unilever (ULVR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Unilever trades in real-time

Unilever (ULVR) Top Chat Posts

Unilever Daily Update: Unilever Plc is listed in the Food Producers sector of the London Stock Exchange with ticker ULVR. The last closing price for Unilever was 3,626.50p.
Unilever Plc has a 4 week average price of 3,469.50p and a 12 week average price of 3,359.50p.
The 1 year high share price is 4,388p while the 1 year low share price is currently 3,267.50p.
There are currently 2,548,776,301 shares in issue and the average daily traded volume is 4,178,552 shares. The market capitalisation of Unilever Plc is £95,247,770,368.37.
giltedge1: I think you are too short termist latest analysis from Nick Train; We remind our clients that Unilever’s share price was c.£5 in 1992, c.£12 in 2002, c.£20 in 2012 and £35 in 2022 (albeit down from that £50 of a couple of years ago). Such a price trajectory seems to us to be consistent with our understanding of the strengths of this company – the ability to generate steadily rising, inflation-proofed earnings over long periods of time from its diverse brands and markets. We do look to management to build further value for shareholders by periodic acquisitions, but just as important, by growing existing still promising brands such as Ben & Jerry’s, Dermalogica, Dove, Hellmann’s and Magnum. Meanwhile, India grew at double digits for Unilever in 2021 and why shouldn’t its 62% stake in Hindustan Lever, the biggest consumer company in India, which has created billions of pounds of market appreciation for Unilever shareholders over the last two decades, carry on doing so for decades to come? I paid £ 18 in 2012 so happy to ride the markets ups & downs & bank a nice quarterly dividend cheque.
laurence llewelyn binliner: Unilever PLC (LSE:ULVR) has given billionaire activist Nelson Peltz a seat on the board after the US corporate raider and company restructuring specialist built a stake through his activist vehicle Trian Partners. Chair Nils Andersen said Peltz would take a non-executive role at the Anglo-Dutch giant after "extensive and constructive discussions" were held with him and the Trian team. Andersen added that the board believes his "experience in the global consumer goods industry will be of value to Unilever as we continue to drive the performance of our business". Peltz said Trian believes the FTSE 100 group "is a company with significant potential, through leveraging its portfolio of strong consumer brands and its geographical footprint. "Trian has made a considerable investment in Unilever. We look forward to working collaboratively with management and the board to help drive Unilever's strategy, operations, sustainability, and shareholder value for the benefit of all stakeholders." The 79-year old billionaire has plenty of form when it comes to shaking things up at consumer brands businesses, having targeted Cadburys in 2007 and joining the board of its new owner Mondelez in 2014 after pushing for its merger with PepsiCo. Heinz and Kraft Foods have also been in his crosshairs, while most recently he was embroiled in a bitter proxy fight in 2017 with Unilever’s main rival Procter & Gamble that was settled with him taking a seat on the board. Since the start of 2018, P&G’s share price has risen by around 63%, with Unilever down 6% over that period. He left the Fairy and Ariel maker in July last year with even P&G noting he had added considerable value to the business.. As strong bounce today and closed trading at 3800p around the same as the Covid crash price March 2020, I look forward to his inputs and helping to drive strategy for growth/recovery..
galeforce1: What have ULVR's competitors done about the Russian situation? For instance Nestle? I'd be surprised if Nestle had pulled the plug on their large Russian business, given the normally pragmatic approach of the Swiss. Personally I admire the management at ULVR for resisting British shoot-yourself-in-the-foot'ism. Instead they are trying to preserve shareholder value by avoiding a futile gesture in Russia that will achieve precisely nothing apart from damage to ULVR. Institutions that feel strongly otherwise can always sell their shares.
giltedge1: Market finding favour with consumer staples today, rotating away from mining stocks. Solid cashflows are a valuable commodity & worth a premium. Noticed ULVR prices in supermarket are now rising, of course a lag Q1 should be down due to margin compression Q2 & onwards improving, share price should improve steadily from here.
mastey: 10% of a cos share price is its current earnings 90% is its future growth prospects and earnings. I am a holder. This recent announcement ridiculous episode has highlighted the stagnate nature of the business and the whole top executive board are void of ideas to advance the business . Simply looking to buy low growth business ,With regret reinforces this. As mentioned early in this thread , who is the biggest fool , I believe it’s GSK for not accepting. I have no doubt we will see the share price fall further but at some point Mr market will say earnings will continue and a floor will be set. What the board need to show the market, it has vision to leverage it’s brands. I know what ever the price my wife will buy Hellman’s and Dove Soap. Trust your assets and leverage them in the best and cheapest way possible. Anyone can buy an over priced business for short term income flows. Finally stop management share incentives etc for mediocre performance. Yes pay up for talent but don’t just use this as a stock answer when so called talent does not perform for their owners , shareholders
brwo349: Just because the ULVR share price is down 11% does not mean the deal is dead. Remember a few years ago when shell paid 47 billion for BG gas, I checked back and according to the Guardian --- >>BG’s share price surged 27% to £12.06 on the news, while Shell shares fell 8.6% to £21.16.<< So the deal may still be on although I hope not.
careful: The lower the ulvr share price the more shares they have to pay to secure the deal. the deal will soon start to tempt gsk. millions more cut price ulvr shares + cash. it is the low ulvr share price that coulds kill this off.
bend1pa: Jope has been CEO of ULVR for 3 years now. The share price is about 10% lower than it was when he took charge. Around that time the FTSE was just under 7000. Today it's only a pitiful 8% higher, but that's still better than the share price performance of ULVR under Jope. It's become increasingly clear that Jope is the wrong man for the job. He has proven over 3 years he is rather good at one thing - losing shareholder value. I think that's a sufficient time period to make a judgement call here.
tabhair: Market usually loves this sort of deal making, so for the ULVR share price to react so negatively tells you all you need to know that this is a hare-brained deal. To ram this through, serious debt would need to be taken on, the dividend would probably need to be cut for awhile, there'd also likely be some disposals (lots of value lost to the investment banks and government). A lot of pain would have to be taken to buy an asset that isn't cheap to acquire, will be low growth and has questionable synergy value. I think in the longer-term, there's a very real prospect that Unilever itself may become a target. It's performing so poorly under the current weak management, is valued well below peers in the US and has already seen a bid from Kraft/Buffett rebuffed. Given how badly the company has performed the last bid I think Unilever is in a much weaker position to knock back any new bids. Needless to say, as a shareholder I am really annoyed by this management team. Terry Smith really nailed it in his comments last week. It's time for shareholders to vote them out during the next AGM.
philanderer: ‘Frustrated&rsquo; Nick Train's fresh lament on tech-mad market In monthly commentary, Train lamented the ‘crushingly pedestrian’ returns from the likes of Unilever (ULVR), the consumer giant behind Marmite and Dove, in a month when Tesla shot up 44% to smash through a $1tn market valuation. ‘Intellectually I agree with the view that it is irrational to be encouraged or discouraged by short-term share price movements. In the short-term prices can be driven by random or irrelevant factors that turn out to have little bearing on the long-term value of a company,’ he said. ‘Like most investors, though, I find it hard not to respond emotionally to short term price moves. When our stocks go up, I feel all is right with the world and I applaud the good sense of the buyers. Contrarily, when they fall, I am affronted by the injustice of it all.’ As the fund itself slipped 0.4% in October versus a 1.8% up-tick for the wider UK market, Train said they ‘had to suck up another 2% fall in Unilever’s share price’. The manager has this year frequently defended ‘archetypal dull plodder Unilever’, which enjoyed a sales boost as consumers stocked up during lockdowns but has since seen the market’s focus pivot to its lack of sustainable growth in recent years. Shares in the £100bn company are down 8% year to date, said Train, noting that its third quarter results ‘turned out not to be as bad as feared’, although rising input costs and fresh lockdowns in Asia ‘took their toll’. Speaking to the stock’s attractions, Train referenced that in recent years Unilever had ‘entered into 500 IP-generating partnerships in areas like plant-based proteins and biotechnology for cleaning’, which can sustain long-term growth. On top of that there are ‘some great, some very strong and, yes, some mediocre consumer brands’, as well as a ‘uniquely high exposure to emerging markets’ – with a considerable part of the business’s value in its India-quoted Hindustan Unilever subsidiary. ‘This combination is not in favour currently and understandably so. In a month when Tesla goes up 44% Unilever looks crushingly pedestrian,’ said Train. ‘On the other hand, Unilever’s quarterly dividend was up 4% on last year.’ HTTPS://;utm_medium=BulkEmail_FundsInsider+Afternoon&utm_campaign=BulkEmail_FundsInsider+Afternoon
Unilever share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220626 20:47:14